þÿ
...Submitting Supporting Documentation in Drug Applications for the Manufacture of Drug.....Estimating the Safe Starting Dose in Clinical Trials for Therapeutics in Adult Healthy.....Help-Seeking" and Other Disease Awareness Communications by or on Behalf of Drug and..
http://www.fda.gov/cder/guidance/guidlist.pdf (score=100)

MDI and DPI Drug Products
...establish a set of criteria to which a drug substance or drug product should conform using.....DPIs, the formulation, and the device with all of its parts including any protective.....also known as oral and nasal metered dose inhalers respectively or MDIs) and inhalation..
http://www.fda.gov/cder/guidance/2180dft.pdf (score=88)

Definition of a Combination Product
...drug/device, biologic/device, drug/biologic, or drug/device/biologic, that are physically, chemically, or otherwise.....drug, device, or biological product where both are required to achieve the intended use.....drug, device, or biological product where both are required to achieve the intended use..
http://www.fda.gov/oc/combination/definition.html (score=403)

Innovative Systems for Delivery of Drugs and Biologics: Scientific, Clinical...
...drug/device, biologic/device, drug/biologic, or drug/device/biologic, that are physically, chemically, or otherwise.....AdvaMed believes that even if the device is not consistent in the indication, dose, rate, or route of administration, the differences.....Shames pointed out that contraception requires a higher dose of drug than patches for treatment of..
http://www.fda.gov/oc/combination/workshop070803.html (score=143)

Preventable Adverse Drug Reactions: A focus on drug interactions
...The first goal is to increase awareness of drug, device and other medical product induced.....2 Ultra-rapid metabolism results in lower blood levels following a standard dose of any.....1 However, they will experience codeine’s adverse effects, particularly if the dose is..
http://www.fda.gov/cder/drug/drugReactions/default.htm (score=97)

Draft Guidance for Industry: Good Pharmacovigilance Practices and...
...Guidelines for Good Epidemiology Practices for Drug, Device and Vaccine Research in the United.....dose, timing of exposure, or patient characteristics.17 Registries can be particularly.....Guidelines for Good Epidemiology Practices for Drug, Device and Vaccine Research in the United..
http://www.fda.gov/cber/gdlns/pharmacovig.htm (score=95)

Microsoft Word - 5767dft.doc
...12 Guidelines for Good Epidemiology Practices for Drug, Device and Vaccine Research in the.....risk of adverse outcomes, such as dose, timing of exposure, or patient characteristics.17.....15 Guidelines for Good Epidemiology Practices for Drug, Device and Vaccine Research in the..
http://www.fda.gov/cder/guidance/5767dft.pdf (score=94)

FR Doc 05-5978
...How important is it that drug and device labeling be consistent with respect to intended use, dose.....A drug, device, or biological product packaged separately that according to its investigational.....dose, another sponsor may develop a separate product to be used with the approved product..
http://www.fda.gov/OHRMS/DOCKETS/98fr/05-5978.htm (score=94)

...Office of Training and Communication Division of Drug Information, HFD-240 Center for Drug Evaluation and Research Food and.....12] Guidelines for Good Epidemiology Practices for Drug, Device and Vaccine Research in the.....dose, schedule, dates, duration); 1. Patient characteristics, including demographic..
http://www.fda.gov/cder/guidance/5767dft.doc (score=94)

Draft Guidance for Industry: Good Pharmacovigilance Practices and...
...12 Guidelines for Good Epidemiology Practices for Drug, Device and Vaccine Research in the.....risk of adverse outcomes, such as dose, timing of exposure, or patient characteristics.17.....15 Guidelines for Good Epidemiology Practices for Drug, Device and Vaccine Research in the..
http://www.fda.gov/cber/gdlns/pharmacovig.pdf (score=94)

...Office of Training and Communication Division of Drug Information, HFD-240 Center for Drug Evaluation and Research Food and.....12] Guidelines for Good Epidemiology Practices for Drug, Device and Vaccine Research in the.....dose, schedule, dates, duration); 1. Patient characteristics, including demographic..
http://www.fda.gov/OHRMS/DOCKETS/98fr/04d-0189-gdl0001-5767dft.doc (score=94)

TESTIMONY JOHN JENKINS, M.D. (MAY 6, 1998)
...125, any food, drug, device, or cosmetic in a self-pressurized container that contains a CFC.....These uses include metered-dose steroid human drugs for nasal inhalation and several drug.....In the past year, FDA has approved three new multi-dose DPIs for marketing in the United..
http://www.fda.gov/ola/1998/cleanai3.htm (score=84)

TESTIMONY JOHN JENKINS, M.D. (APRIL 2, 1998)
...125, any food, drug, device, or cosmetic in a self-pressurized container that contains a CFC.....These uses include metered-dose steroid human drugs for nasal inhalation and several drug.....FDA tentatively has determined that metered-dose corticosteroid human drugs for oral..
http://www.fda.gov/ola/1998/cleanai2.htm (score=84)

CDER 2003 Report to the Nation
...We have successfully developed computer models to estimate the safe starting dose for.....Last year, we at the Center for Drug Evaluation and Research worked hard to meet the.....The current method for estimating the starting dose is highly inexact and requires the use..
http://www.fda.gov/cder/reports/rtn/2003/rtn2003.htm (score=83)

Preventable Adverse Drug Reactions: A focus on drug interactions
...The first goal is to increase awareness of drug, device and other medical product induced.....2 Ultra-rapid metabolism results in lower blood levels following a standard dose of any.....1 However, they will experience codeine’s adverse effects, particularly if the dose is..
http://www.fda.gov/cder/drug/drugreactions/default.htm (score=81)

FDA Chemical and Biological Emergency Response Plan
...Providing sponsors and other stakeholders with guidance on the development of drug and.....Toxic Dose, Low: The lowest administered dose of a material capable of producing a defined toxic effect in specified test.....drug-device, drug-biologic, and device-biologic products). OCP works with FDA Centers to..
http://www.fda.gov/oc/ocm/cbplan.html (score=80)

Guidance for Industry: Clinical Development Programs for Drugs, Devices, and...
...consideration, it is desirable for sponsors to build into their repeat-dose clinical.....coordinated evaluation of drug levels, receptor saturation, antidrug antibodies, and.....Ensuring safety during the development of a drug, biologic, or device can be optimized by..adequate..
http://www.fda.gov/cber/gdlns/rheumcln.pdf (score=76)

Las Vegas Injury Lawyer